REFRACTORY MICROSATELLITE STABLE COLORECTAL CARCINOMA

Clinical trials for REFRACTORY MICROSATELLITE STABLE COLORECTAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY MICROSATELLITE STABLE COLORECTAL CARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY MICROSATELLITE STABLE COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat colon cancer patients

Disease control Recruiting now

This early-stage trial is testing whether combining two cancer drugs—abemaciclib and 5-fluorouracil—is safe and tolerable for people with advanced colorectal cancer that has spread and stopped responding to standard treatments. Researchers will enroll 39 adults to find the best d…

Matched conditions: REFRACTORY MICROSATELLITE STABLE COLORECTAL CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

REFRACTORY MICROSATELLITE STABLE COLORECTAL CARCINOMA

Get alerted when new REFRACTORY MICROSATELLITE STABLE COLORECTAL CARCINOMA trials appear

New hope for Tough-to-Treat colon cancer patients